Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

BioFocus and Usher III Initiative partner to discover drugs for Usher's syndrome type III

Sep. 8, 2010

Emerald BioStructure and SomaLogic collaborate on SOMAmers and small-molecule therapeutics

Sep. 7, 2010

MorphoSys and Absynth collaborate on research into infectious disease

Sep. 7, 2010

Stallergenes and Shionogi partner on two immunotherapy tablets

Sep. 7, 2010

Nabi enters agreement with Diosynth for manufacture of NicVAX nicotine vaccine

Sep. 7, 2010

MSD and Faes Farma to market sitagliptin and sitagliptin/metformin in Spain

Sep. 6, 2010

Ipsen gains rights to fipamezole outside of North America and Japan

Sep. 3, 2010

iBio, Fraunhofer and GE Healthcare to partner for iBioLaunch platform

Sep. 3, 2010

Orexigen and Takeda to co-commercialize Contrave in North America

Sep. 3, 2010

MorphoSys and Absynth partner for MRSA treatments

Sep. 3, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...